Download presentation
Presentation is loading. Please wait.
1
Antimicrobial Resistance at GLA
2
All Common Nosocomial Urine GNR 1991 - 2015
Cefepime substituted for ceftazidime as of 2004; * P. aeruginosa isolates excluded from analysis
3
All Common Nosocomial Non-Urine GNR 1992 - 2015
Cefepime substituted for ceftazidime as of 2004; * P. aeruginosa isolates excluded from analysis
4
Nosocomial E. coli and K. pneumoniae Urine Isolates: 2006 - 2014
5
Community E. coli and K. pneumoniae Urine Isolates: 2006 - 2015
6
S. aureus: Outpatient Resistance 1997 - 2015
7
S. aureus: Nosocomial Resistance 1997 – 2015
Similar presentations
![Fig. 3. Target population for vaccines in the 21st century by Rappuoli et al. [25]. (A) The most important vaccines for each age group are reported. (B)](/80/13461111/big_thumb.jpg "Fig. 3. Target population for vaccines in the 21st century by Rappuoli et al. [25]. (A) The most important vaccines for each age group are reported. (B)>")